SHED THE CAVALIER ATTITUDE
A Parliamentary Panel has asked the Department of Pharmaceuticals to remove administrative delays in the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme, which saw only 51% expenditure in 2024-25. The scheme, with a Rs. 5,000 crore outlay, aims to promote industry-academia linkage for R&D in priority areas.
A Parliamentary Panel has asked the Department of Pharmaceuticals (DoP) to remove administrative delays in the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme. The scheme, notified in August 2023 with a Rs. 5,000 crore outlay, aims to promote industry-academia linkage for R&D in priority areas. In 2024-25, actual expenditure was Rs. 48.44 crore, only 51% of the Revised Estimates of Rs. 95 crore, due to delays in tendering and hiring staff. The Panel noted that administrative delays were within the DoP's control and recommended corrective steps to avoid future bottlenecks. For 2025-26, fund utilization stands at 44% as of January 31, 2026. The PRIP scheme aims to build IP-driven products and create a pan-India digital Pharma-MedTech innovation exchange to support innovators.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.